TP53 and cancer: Overall, our results demonstrate that a high level of TICRR promotes proliferation of cancer cell through firing more replication origins, while reducing TICRR expression triggers the DNA damage-p53 pathway, leading to inhibition of proliferation and enhancement of apoptosis, at least in p53-wild cancer cells (Figure S9).